Neuroendocrinology of ageing

Age and Ageing

Volumn 30, Issue 4, 2001, Pages 279-287

  Rehman, Habib U ^a   Masson, Ewan A ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Ageing; Hypothalamic neuroendocrine system

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; GLUTAMATE DECARBOXYLASE; GONADORELIN; GROWTH HORMONE; NORADRENALIN; OPIATE PEPTIDE; PROOPIOMELANOCORTIN; SEROTONIN; SODIUM; TESTOSTERONE; THYROTROPIN;

ADENOHYPOPHYSIS; AGED; AGING; ALZHEIMER DISEASE; AMINO ACID TRANSPORT; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DOPAMINERGIC SYSTEM; FEMALE; HORMONAL REGULATION; HUMAN; HYPONATREMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROENDOCRINE SYSTEM; NEUROENDOCRINOLOGY; NORADRENERGIC SYSTEM; OSTEOPOROSIS; PARKINSON DISEASE; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEROTONINERGIC SYSTEM; SLEEP DISORDER; VASCULAR DISEASE;

AGING; AMINO ACID TRANSPORT SYSTEMS; ANIMALS; CARRIER PROTEINS; CHOLINE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; ENDOCRINE SYSTEM; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MONOAMINE OXIDASE; PEPTIDES; PITUITARY GLAND, ANTERIOR; PROLACTIN; SEROTONIN;

EID: 0034857281     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/30.4.279     Document Type: Review

References (97)

1. Lack of high affinity transport system for dopamine in the median eminence and posterior pituitary
2. Characteristics of dopaminergic neurons in the aged male rat
3. Dopamine and serotonin systems in human and rodent brain: Effects of age and neurodegenerative disease
4. Aging produces a specific pattern of striatal loss: Implications for the etiology of idiopathic Parkinson's disease
5. Age-related changes in the nigrostriatum: A behavioural and biochemical analysis
6. The effect of age on the activity and molecular properties of human brain monoamine oxidase
7. Region-specific loss of glutamate innervation in Alzheimer's disease
8. Increased brain dopamine and dopamine receptors in schizophrenia
9. Neurochemistry
10. Aging monoamines and monoamine oxidase
11. Neurochemistry of aging
12. Aging: Hypothalamic catecholamines, neuroendocrine-immune interactions and dietary restriction
13. Neurochemical studies of Alzheimer's disease
14. Neurochemical correlates of major depression in primary dementia
15. Occurrence and localization of catecholamines in the human brain
16. Effect of aging in human pre- and postsynaptic serotonin binding sites
17. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects
18. Accelerated ageing or selective neuronal loss as an important cause of dementia
19. Aging, Alzheimer's disease and the cholinergic system of the basal forebrain
20. Muscarinic and dopaminergic receptors in aging human brain
21. Selective loss of central cholinergic neurones in Alzheimer's disease
22. Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer's type dementia
23. CNS nicotinic receptors: Therapeutic target in neurodegeneration
24. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia and combined dementia
25. Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia
26. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: A postmortem study
27. The neurochemistry of Alzheimer's disease
28. Estrogen-induced hypothalamic beta-endorphin neuron loss: A possible model of hypothalamic aging
29. α-Melanocyte-stimulating hormone: A possible neuronal marker of the aging brain
30. Age-related changes in central nervous system enkephalins and substance P
31. Leydig cell function in normal men: Effect of age, lifestyle, residence, diet and activity
32. Inhibin and age in men
33. Clinical problems in reproductive neuroendocrinology of men
34. Combined deficits in the somatotropic and gonadotropic axes in healthy aging men: An appraisal of neuroendocrine mechanisms by deconvolution analysis
35. Age variation of the 24-hour mean plasma concentration of androgens, estrogens and gonadotropins in normal adult men
36. The effect of aging in normal men on bioavailable testosterone and luteinising hormone secretion. Response to clomiphene citrate
37. The influence of age, alcohol consumption and body build on gonadal function in man
38. Decreased bio-available testosterone in aging normal and impotent men
39. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men
40. Circadian rhythm of serum immunoreactive inhibin in young and elderly men
41. Reproductive hormones in aging men: I. Measurement of sex steroids, basal luteinizing hormone and Leydig cell response to human chorionic gonadotrophin
42. Reproductive hormones in aging men: II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone
43. The gonadotropin suppressive activity of androgen is increased in elderly men
44. Gonadotropins, testosterone and the aging male
45. Neuroendocrinology of aging in humans: Attenuated sensitivity to sex steroid feedback in elderly postmenopausal women
46. Reinitiation of estrous cycles in old constant-estrous rats by central-acting drugs
47. Evidence that a decrease in opioid tone may evoke preovulatory luteinizing hormone release in rat
48. Neuroendocrine involvement in aging: Evidence from studies of reproductive aging and caloric restriction
49. Cognitive function in nondemented older women who took estrogen after menopause
50. Estrogen replacement therapy and cognitive function in older women
51. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease: A randomized controlled trial
52. Testosterone replacement in older hypogonadal men: A 12 month randomized controlled trial
53. Effects of testosterone supplementation in the aging male
54. Dehydroepiandrosterone (DHEA) and Aging
55. Dehydroepiandrosterone (DHEA): A fountain of youth
56. Plasma dehydroepiandrosterone sulfate in nursing home men
57. Chrononeuroendocrine markers of the aging brain
58. Endocrines and aging
59. Basal cortisol levels and cognitive deficits in human aging
60. Age-related change in the twenty-four-hour spontaneous secretion of growth hormone
61. Interrelations between sleep and somatotropic axis
62. The relationship between insulin-like growth factor-1, adiposity and aging
63. Pulsatile growth hormone secretion in older persons is enhanced by fasting without relationship to sleep stages
64. Low somatomedin-C levels in older men rise in response to growth hormone administration
65. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men
66. Age-related reduction of human growth hormone-binding sites in the human brain
67. L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats
68. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men
69. 1-adrenergic receptor involvement in the LH surge in ovariectomized estrogen-primed rats
70. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women
71. Effects of human growth hormone in men over 60 years old
72. Acute growth hormone effects on amino acid and lipid metabolism
73. Growth hormone acutely stimulates forearm muscle protein synthesis in normal subjects
74. The effect of growth hormone (GH) administration in GH-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition
75. Growth hormone in the regulation of hyperlipidemia
76. Increased myocardial contractility following growth hormone administration in normal men
77. A placebo-controlled study of growth hormone in patients with congestive heart failure
78. Are patients with acromegaly at increased risk for neoplasia?
79. Insulin-like growth factor-1: A prognostic factor of knee osteoarthritis
80. Thyroid dysfunction in elderly hospitalized patients
81. Thyroid hormone indices in adult healthy subjects: No influence of aging
82. Luteinizing hormone releasing hormone and thyrotropin-releasing hormone in the hypothalamus of women: Effects of age and reproductive status
83. Plasma arginine vasopressin in dehydrated elderly patients
84. The response of arginine vasopressin to ethanol and hypertonic saline in man: The impact of aging
85. Age-related failure of volume-pressure-mediated vasopressin release
86. Abnormal arginine vasopressin response to cigarette smoking and metoclopramide (but not to insulin-induced hypoglycemia) in elderly subjects
87. Altered water excretion in healthy elderly men
88. Ageing of the human hypothalamus
89. Aging and hormones
90. Neuroendocrine rhythms and sleep in aging men
91. Influence of age on serum prolactin levels in men and women
92. The changes in serum levels of FSH, LH, LHα and β-subunit and prolactin and their responses to synthetic LH-RH and TRH in normal subjects with aging [In Japanese]
93. Effect of age and sex on circulating and pituitary prolactin levels in humans
94. Neuroendocrine rhythms and sleep in aging men
95. Increase in the lifespan of rats following polypeptide pineal extract
96. Pineal control of aging: Effect of melatonin and pineal grafting on aging mice
97. Circadian melatonin and young-to-old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats